search
Back to results

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

Primary Purpose

Non-Small-Cell Lung Cancer

Status
Recruiting
Phase
Phase 2
Locations
International
Study Type
Interventional
Intervention
CAB-AXL-ADC
PD-1 inhibitor
Sponsored by
BioAtla, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Non-Small-Cell Lung Cancer focused on measuring Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients must have measurable disease.
  • Age ≥ 18 years
  • Adequate renal function
  • Adequate liver function
  • Adequate hematological function
  • Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
  • Life expectancy of at least three months.

Exclusion Criteria:

  • Patients must not have clinically significant cardiac disease.
  • Patients must not have known non-controlled CNS metastasis.
  • Patients must not have had prior therapy with a conjugated or unconjugated auristatin derivative/vinca-binding site targeting payload.
  • Patients must not have a history of ≥ Grade 3 allergic reactions to mAb therapy as well as known or suspected allergy or intolerance to any agent given during this study.
  • Patients must not have had major surgery within 4 weeks before first BA3011
  • Patients must not have known human immunodeficiency virus (HIV) infection, active hepatitis B and/or hepatitis C.
  • Patients must not be women who are pregnant or breast feeding.

Sites / Locations

  • City of Hope - DuarteRecruiting
  • California Research InstituteRecruiting
  • USC NorrisRecruiting
  • Cedars-SinaiRecruiting
  • University of California, San Diego (UCSD) - Moores Cancer CenterRecruiting
  • American Institute of ResearchRecruiting
  • University of Colorado Anschutz Medical CampusRecruiting
  • Florida Cancer Specialists & Research InstituteRecruiting
  • Florida Cancer Specialists & Research InstituteRecruiting
  • Florida Cancer SpecialistRecruiting
  • Moffitt Cancer CenterRecruiting
  • Florida Cancer SpecialistsRecruiting
  • Augusta University - Georgia Cancer CenterRecruiting
  • Baptist Health Systems
  • University of KentuckyRecruiting
  • Norton Cancer Institute, Brownsboro Hospital CampusRecruiting
  • Hematology/Oncology ClinicRecruiting
  • Dana-Farber Cancer InstituteRecruiting
  • University of Michigan Comprehensive Cancer CenterRecruiting
  • Comprehensive Cancer Centers of Nevada
  • OptumCare Cancer Care
  • Roswell ParkRecruiting
  • NYU Langone HealthRecruiting
  • FirstHealth Outpatient Cancer CenterRecruiting
  • Gabrail Cancer Research Center
  • The Lindner Research Center at the Christ HospitalRecruiting
  • UPMC Cancer CenterRecruiting
  • Medical University of South Carolina- Hollings Cancer CenterRecruiting
  • Sarah Cannon Research InstituteRecruiting
  • Mary Crowley Cancer ResearchRecruiting
  • MD AndersonRecruiting
  • Berlin Protestant Lung Hospital
  • German Red Cross Clinics Berlin-Mitte
  • Clinics Essen-Mitte
  • Asklepios Clinical Center Harburg
  • Henry Dunant Hospital Center
  • Sotiria Chest Diseases Hospital of Athens
  • Metropolitan Hospital Perseus Healthcare Group SA
  • Bioclinic Thessaloniki
  • European Interbalkan Medical Center
  • ICON Cancer CentreRecruiting
  • Queen Mary HospitalRecruiting
  • Hong Kong United Oncology CentreRecruiting
  • Specialistic Oncologic Hospital NU-MED
  • Polish Mother's Memorial Hospital-Research InstituteRecruiting
  • Institute of Genetics and Immunology GENIMRecruiting
  • Maria Sklodowska-Curie - National Research Institute of Oncology
  • MED-Polonia, Sp. z o.o. (LLC)Recruiting
  • Hospital Universitario Virgen de Valme
  • Hospital del Mar
  • Hospital de la Santa Creu i Sant Pau
  • Catalan Institute of Oncology, Hospital Duran i Reynals
  • Clinica Universidad de Navarra
  • University Hospital 12 de Octubre
  • Kaoshiung Chang Gung Memorial HospitalRecruiting
  • Taichung Veterans General Hospital
  • National Cheng Kung University HospitalRecruiting
  • National Taiwan University HospitalRecruiting
  • Taipei Veterans General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

CAB-AXL-ADC (BA3011)

CAB-AXL-ADC (BA3011)+PD-1 inhibitor

Arm Description

CAB-AXL-ADC (BA3011) alone

CAB-AXL-ADC (BA3011) with PD-1 inhibitor

Outcomes

Primary Outcome Measures

Confirmed Objective Response Rate (ORR) per RECIST v1.1
Proportion of patients who achieve a confirmed CR or PR according to RECIST v1.1
Incidence of Adverse Events (AEs)or Serious Adverse Events (SAEs) as assessed by CTCAE v4.03/v5
Measured by frequency and severity of adverse events as assessed by CTCAE v4.03/v5

Secondary Outcome Measures

Duration of response (DOR)
Time from the first documented OR until the first documented disease progression or death (due to any cause), whichever occurs first
Progression-free survival (PFS)
Time from the first dose of IP until the first documentation of disease progression or death due to any cause, whichever occurs first.
Best overall response (BOR)
All post-baseline disease assessments that occur prior to the initiation of subsequent anticancer therapy
Disease control rate (DCR)
Proportion of patients with a best overall response of confirmed CR, confirmed PR, or stable disease (SD) ≥ 12 weeks.
Time to response (TTR)
Time from the first dose of investigational product until the first documentation of OR.
Overall survival (OS)
Time from the first dose of BA3021 treatment until death due to any cause.
Percent change from baseline in target lesion sum of diameters

Full Information

First Posted
December 8, 2020
Last Updated
September 22, 2023
Sponsor
BioAtla, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04681131
Brief Title
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
Official Title
A Phase 2 Study of BA3011 Alone and in Combination With PD-1 Inhibitor in Adult Patients With Metastatic Non-small Cell Lung Cancer (NSCLC) Who Had Prior Disease Progression on a PD-1/L-1 Inhibitor
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 17, 2021 (Actual)
Primary Completion Date
August 2025 (Anticipated)
Study Completion Date
August 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
BioAtla, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Detailed Description
This is a multi-center, open-label, Phase 2 study designed to evaluate the safety, tolerability, PK, immunogenicity, and antitumor activity of BA3011, a conditionally active biologic (CAB) AXL-targeted antibody drug conjugate (CAB-AXL-ADC), alone and in combination with PD-1 inhibitor in patients with metastatic non-small cell lung cancer (NSCLC).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-Small-Cell Lung Cancer
Keywords
Cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
240 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CAB-AXL-ADC (BA3011)
Arm Type
Experimental
Arm Description
CAB-AXL-ADC (BA3011) alone
Arm Title
CAB-AXL-ADC (BA3011)+PD-1 inhibitor
Arm Type
Experimental
Arm Description
CAB-AXL-ADC (BA3011) with PD-1 inhibitor
Intervention Type
Biological
Intervention Name(s)
CAB-AXL-ADC
Other Intervention Name(s)
BA3011
Intervention Description
Conditionally active biologic anti-AXL antibody drug conjugate
Intervention Type
Biological
Intervention Name(s)
PD-1 inhibitor
Intervention Description
PD-1 inhibitor
Primary Outcome Measure Information:
Title
Confirmed Objective Response Rate (ORR) per RECIST v1.1
Description
Proportion of patients who achieve a confirmed CR or PR according to RECIST v1.1
Time Frame
Up to 24 months
Title
Incidence of Adverse Events (AEs)or Serious Adverse Events (SAEs) as assessed by CTCAE v4.03/v5
Description
Measured by frequency and severity of adverse events as assessed by CTCAE v4.03/v5
Time Frame
Up to 24 months
Secondary Outcome Measure Information:
Title
Duration of response (DOR)
Description
Time from the first documented OR until the first documented disease progression or death (due to any cause), whichever occurs first
Time Frame
Up to 24 months
Title
Progression-free survival (PFS)
Description
Time from the first dose of IP until the first documentation of disease progression or death due to any cause, whichever occurs first.
Time Frame
Up to 24 months
Title
Best overall response (BOR)
Description
All post-baseline disease assessments that occur prior to the initiation of subsequent anticancer therapy
Time Frame
Up to 24 months
Title
Disease control rate (DCR)
Description
Proportion of patients with a best overall response of confirmed CR, confirmed PR, or stable disease (SD) ≥ 12 weeks.
Time Frame
Up to 24 months
Title
Time to response (TTR)
Description
Time from the first dose of investigational product until the first documentation of OR.
Time Frame
Up to 24 months
Title
Overall survival (OS)
Description
Time from the first dose of BA3021 treatment until death due to any cause.
Time Frame
Up to 24 months
Title
Percent change from baseline in target lesion sum of diameters
Time Frame
Up to 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients must have measurable disease. Age ≥ 18 years Adequate renal function Adequate liver function Adequate hematological function Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Life expectancy of at least three months. Exclusion Criteria: Patients must not have clinically significant cardiac disease. Patients must not have known non-controlled CNS metastasis. Patients must not have had prior therapy with a conjugated or unconjugated auristatin derivative/vinca-binding site targeting payload. Patients must not have a history of ≥ Grade 3 allergic reactions to mAb therapy as well as known or suspected allergy or intolerance to any agent given during this study. Patients must not have had major surgery within 4 weeks before first BA3011 Patients must not have known human immunodeficiency virus (HIV) infection, active hepatitis B and/or hepatitis C. Patients must not be women who are pregnant or breast feeding.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
BioAtla Medical Affairs
Phone
858-558-0708
Ext
3333
Email
medicalaffairs@bioatla.com
Facility Information:
Facility Name
City of Hope - Duarte
City
Duarte
State/Province
California
ZIP/Postal Code
91010
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Abrar Khan
Email
akhan@coh.org
First Name & Middle Initial & Last Name & Degree
Mykola Onyshchenko, MD
Facility Name
California Research Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90027
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Clare Gregorio
Email
cg@caresinst.com
First Name & Middle Initial & Last Name & Degree
Ghassan Al-Jazayrly, MD
Facility Name
USC Norris
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristina Massopust
Email
massopust_k@med.usc.edu
First Name & Middle Initial & Last Name & Degree
Jorge Nieva, MD
Facility Name
Cedars-Sinai
City
Los Angeles
State/Province
California
ZIP/Postal Code
90048
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cynthia Martin
Email
cynthia.martin@cshs.org
First Name & Middle Initial & Last Name & Degree
Sukhmani Padda, MD
Facility Name
University of California, San Diego (UCSD) - Moores Cancer Center
City
San Diego
State/Province
California
ZIP/Postal Code
92093
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katherine Velasco
Email
kcvelasco@health.ucsd.edu
First Name & Middle Initial & Last Name & Degree
Lyudmila Bazhenova
Facility Name
American Institute of Research
City
Whittier
State/Province
California
ZIP/Postal Code
90603
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kirsten Bettino
Email
kbettino@airesearch.us
First Name & Middle Initial & Last Name & Degree
Richy Agajanian, MD
Facility Name
University of Colorado Anschutz Medical Campus
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nathan Plattner
Phone
720-848-0696
Email
nathan.plattner@cuanschutz.edu
First Name & Middle Initial & Last Name & Degree
David Camidge
Facility Name
Florida Cancer Specialists & Research Institute
City
Fleming Island
State/Province
Florida
ZIP/Postal Code
32003
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sheila Gagne
Phone
904-269-6526
Email
sgagne@flcancer.com
First Name & Middle Initial & Last Name & Degree
Augusto Villegas
Facility Name
Florida Cancer Specialists & Research Institute
City
Fort Myers
State/Province
Florida
ZIP/Postal Code
33916
Country
United States
Individual Site Status
Recruiting
Facility Contact:
Phone
239-274-9930
First Name & Middle Initial & Last Name & Degree
Ivor Percent
Facility Name
Florida Cancer Specialist
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33705
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lukas Escobar
Phone
727-216-1143
Email
lukas.escobar@flcancer.com
First Name & Middle Initial & Last Name & Degree
Vipul Patel
Facility Name
Moffitt Cancer Center
City
Tampa
State/Province
Florida
ZIP/Postal Code
33612
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
CTLC-Warehouse and Inventory Control
Email
CTLC.Warehouse@moffitt.org
First Name & Middle Initial & Last Name & Degree
Andreas Saltos, MD
Facility Name
Florida Cancer Specialists
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33401
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
De'Dra Kelly
Phone
561-366-4100
Email
dkelly@flcancer.com
First Name & Middle Initial & Last Name & Degree
Eric Harris
Facility Name
Augusta University - Georgia Cancer Center
City
Augusta
State/Province
Georgia
ZIP/Postal Code
30912
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kelly Jenkins
Email
kejenkins@augusta.edu
First Name & Middle Initial & Last Name & Degree
Girindra Raval, MD
Facility Name
Baptist Health Systems
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40503
Country
United States
Individual Site Status
Completed
Facility Name
University of Kentucky
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40536
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Howard
Email
sarah.kamer@uky.edu
First Name & Middle Initial & Last Name & Degree
Susanne Arnold, MD
Facility Name
Norton Cancer Institute, Brownsboro Hospital Campus
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40241
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rebecca Gash
Email
rebecca.gash@nortonhealthcare.org
First Name & Middle Initial & Last Name & Degree
Adam Lye, MD
Facility Name
Hematology/Oncology Clinic
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70809
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aimee Alumbaugh
Phone
225-761-3951
Email
aimee.alumbaugh@aoncology.com
First Name & Middle Initial & Last Name & Degree
Michael Castine
Facility Name
Dana-Farber Cancer Institute
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stefania Molinaro
Email
Stefania_Molinaro@DFCI.HARVARD.EDU
First Name & Middle Initial & Last Name & Degree
Julia Rotow, MD
Facility Name
University of Michigan Comprehensive Cancer Center
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nausheen Virk
Email
Nvirk2@hfhs.org
First Name & Middle Initial & Last Name & Degree
Shirish Gadgeel, MD
Facility Name
Comprehensive Cancer Centers of Nevada
City
Henderson
State/Province
Nevada
ZIP/Postal Code
89014
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
OptumCare Cancer Care
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89169
Country
United States
Individual Site Status
Completed
Facility Name
Roswell Park
City
Buffalo
State/Province
New York
ZIP/Postal Code
14263
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julianne Hergenroder
Phone
800-767-9355
Email
askroswell@roswellpark.org
First Name & Middle Initial & Last Name & Degree
Grace Dy, MD
Facility Name
NYU Langone Health
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zaykov Viktor
Email
viktor.zaykov@nyulangone.org
First Name & Middle Initial & Last Name & Degree
Elaine Shum, MD
Facility Name
FirstHealth Outpatient Cancer Center
City
Pinehurst
State/Province
North Carolina
ZIP/Postal Code
28374
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julie Williams
Phone
910-715-1922
Email
jcwilliams@firsthealth.org
First Name & Middle Initial & Last Name & Degree
Charles Kuzma
Facility Name
Gabrail Cancer Research Center
City
Canton
State/Province
Ohio
ZIP/Postal Code
44718
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
The Lindner Research Center at the Christ Hospital
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Abby Reed
Email
abby.reed@thechristhospital.com
First Name & Middle Initial & Last Name & Degree
Alexander Starodub, MD
Facility Name
UPMC Cancer Center
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15232
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Deb Mayr
Phone
412-623-4029
Email
mayrdc@upmc.edu
First Name & Middle Initial & Last Name & Degree
Liza Villaruz
Facility Name
Medical University of South Carolina- Hollings Cancer Center
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29407
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexandra Leitner
Email
leitnera@musc.edu
First Name & Middle Initial & Last Name & Degree
Mariam Alexander, MD
Facility Name
Sarah Cannon Research Institute
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley Scott Maheu
Phone
615-341-7875
Email
ashley.scott4@sarahcannon.com
First Name & Middle Initial & Last Name & Degree
Melissa Johnson
Facility Name
Mary Crowley Cancer Research
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Terrell Martinez
Phone
214-658-1946
Email
tmartinez@marycrowley.org
First Name & Middle Initial & Last Name & Degree
Reva Schneider
Facility Name
MD Anderson
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Angela McGaskey
Email
anmcgaskey@mdanderson.org
First Name & Middle Initial & Last Name & Degree
Carl Gay, MD
Facility Name
Berlin Protestant Lung Hospital
City
Berlin
ZIP/Postal Code
13125
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Norman Golchert
Email
norman.golchert@jsd.de
First Name & Middle Initial & Last Name & Degree
Christian Grohé
Facility Name
German Red Cross Clinics Berlin-Mitte
City
Berlin
ZIP/Postal Code
13359
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jeanette Natschke
Email
j.natschke@drk-kliniken-berlin.de
First Name & Middle Initial & Last Name & Degree
Bernd Schmidt
Facility Name
Clinics Essen-Mitte
City
Essen
ZIP/Postal Code
45136
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thea Resch
Email
t.resch@kem-med.com
First Name & Middle Initial & Last Name & Degree
Daniel Christoph
Facility Name
Asklepios Clinical Center Harburg
City
Hamburg
ZIP/Postal Code
21075
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicole Hundrieser
Email
n.hundrieser@asklepios.com
First Name & Middle Initial & Last Name & Degree
Claas Wesseler
Facility Name
Henry Dunant Hospital Center
City
Athens
ZIP/Postal Code
115 26
Country
Greece
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dimitrios Tzanos
Email
dtzanos86@gmail.com
First Name & Middle Initial & Last Name & Degree
Giannis Mountzios
Facility Name
Sotiria Chest Diseases Hospital of Athens
City
Athens
ZIP/Postal Code
11527
Country
Greece
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Roza Mariatou
Email
rmariatou@yahoo.gr
First Name & Middle Initial & Last Name & Degree
Syrigos Konstantinos
Facility Name
Metropolitan Hospital Perseus Healthcare Group SA
City
Piraeus
ZIP/Postal Code
185 47
Country
Greece
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nephely Alevra
Email
nephely.alevra@gmail.com
First Name & Middle Initial & Last Name & Degree
Helena Linardou
Facility Name
Bioclinic Thessaloniki
City
Thessaloniki
ZIP/Postal Code
546 22
Country
Greece
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Panagiota Papadopoulou
Email
giota0806@gmail.com
First Name & Middle Initial & Last Name & Degree
Ioannis Boukovinas
Facility Name
European Interbalkan Medical Center
City
Thessaloniki
ZIP/Postal Code
570 01
Country
Greece
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eleni Papadopoulou
Email
elenhpap_1986@hotmail.com
First Name & Middle Initial & Last Name & Degree
Sofia Baka
Facility Name
ICON Cancer Centre
City
Hong Kong
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alice Ng, MD
Facility Name
Queen Mary Hospital
City
Hong Kong
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Winnie Chan
Email
winc@hku.hk
First Name & Middle Initial & Last Name & Degree
Roland Leung, MD
Facility Name
Hong Kong United Oncology Centre
City
Kowloon
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katherine Chau
Email
Katherine.Chau@hkuoc.hk
First Name & Middle Initial & Last Name & Degree
Li Yu Chung, MD
Facility Name
Specialistic Oncologic Hospital NU-MED
City
Tomaszów Mazowiecki
State/Province
Lodzkie
ZIP/Postal Code
97-200
Country
Poland
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Beata Głogowska
Email
beata.glogowska@nu-med.pl
First Name & Middle Initial & Last Name & Degree
Ewa Chmielowska
Facility Name
Polish Mother's Memorial Hospital-Research Institute
City
Łódź
State/Province
Lodzkie
ZIP/Postal Code
93-338
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marta Grubiak
Email
grubiak.marta@gmail.com
First Name & Middle Initial & Last Name & Degree
Ewa Kalinka
Facility Name
Institute of Genetics and Immunology GENIM
City
Lublin
State/Province
Lubelskie
ZIP/Postal Code
20-609
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katarzyna Reszka
Email
katarzyna.reszka1203@gmail.com2
First Name & Middle Initial & Last Name & Degree
Izabela Chmielewska
Facility Name
Maria Sklodowska-Curie - National Research Institute of Oncology
City
Warsaw
State/Province
Mazowieckie
ZIP/Postal Code
02-781
Country
Poland
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Malgorzata Kozlik
Email
malgorzata.kozlik@pib-nio.pl
First Name & Middle Initial & Last Name & Degree
Dariusz Kowalski
Facility Name
MED-Polonia, Sp. z o.o. (LLC)
City
Poznań
State/Province
Wielkopolskie
ZIP/Postal Code
60-693
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katarzyna Ewert
Email
katarzyna.ewert@medpolonia.pl
First Name & Middle Initial & Last Name & Degree
Rodryg Ramlau
Facility Name
Hospital Universitario Virgen de Valme
City
Sevilla
State/Province
Andalusia
ZIP/Postal Code
41014
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Javier Díaz Álvarez
Email
valmeoncologia@yahoo.es
First Name & Middle Initial & Last Name & Degree
Jose Fuentes Pradera
Facility Name
Hospital del Mar
City
Barcelona
State/Province
Catalonia
ZIP/Postal Code
08003
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosa Lopez Parellada
Email
rlopezparellada@psmar.cat
First Name & Middle Initial & Last Name & Degree
Alvaro Taus
Facility Name
Hospital de la Santa Creu i Sant Pau
City
Barcelona
State/Province
Catalonia
ZIP/Postal Code
08041
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laia Lavernia Rossell
Email
LLavernia@santpau.cat
First Name & Middle Initial & Last Name & Degree
Ivana Sullivan
Facility Name
Catalan Institute of Oncology, Hospital Duran i Reynals
City
Barcelona
State/Province
Catalonia
ZIP/Postal Code
08908
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Ramos Luna
Email
aramosl@idibell.cat
First Name & Middle Initial & Last Name & Degree
Ernest Nadal
Facility Name
Clinica Universidad de Navarra
City
Pamplona
State/Province
Navarra
ZIP/Postal Code
31008
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eduardo De la Guardia
Email
edelaguardia@unav.es
First Name & Middle Initial & Last Name & Degree
Gonzalo Hinojal
Facility Name
University Hospital 12 de Octubre
City
Madrid
ZIP/Postal Code
28041
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maripaz Soriano
Email
unidadfase1.imas12@h12o.es
First Name & Middle Initial & Last Name & Degree
Jon Zugazagoitia Fraile
Facility Name
Kaoshiung Chang Gung Memorial Hospital
City
Kaohsiung
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chin-Chou Wang, MD
Facility Name
Taichung Veterans General Hospital
City
Taichung
Country
Taiwan
Individual Site Status
Active, not recruiting
Facility Name
National Cheng Kung University Hospital
City
Tainan
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chia-Tien
Email
120430@ntuh.gov.tw
First Name & Middle Initial & Last Name & Degree
Wu-Chou Su, MD
Facility Name
National Taiwan University Hospital
City
Taipei
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fang-Syuan Lin
Email
120430@ntuh.gov.tw
First Name & Middle Initial & Last Name & Degree
James Yang, MD
Facility Name
Taipei Veterans General Hospital
City
Taipei
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chi-Lun Chang
Email
z19901108@gmail.com
First Name & Middle Initial & Last Name & Degree
Yuh-Min Chen, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

We'll reach out to this number within 24 hrs